1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Just a moment...
1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
<h1>Pharmaceutical company announces IPO opening July 9 with 27.56 crore issue size on BSE SME platform</h1> A pharmaceutical and nutraceutical company headquartered in Navi Mumbai announced its IPO opening on July 9, 2025, with a proposed issue size of 27.56 crores. The shares will be listed on BSE SME platform through 100% book-building process. The company, established in 2019, operates in over 10 countries, primarily in African markets, manufacturing tablets, capsules, syrups, ointments, and injectables. Net proceeds will fund machinery acquisition, working capital requirements, debt repayment, and general corporate purposes. The issue closes on July 11, 2025, with price band of 115-123 per equity share.